Advanced maternal age (AMA), typically defined as maternal age ≥35 years at delivery, has become a global public health concern with significant demographic shifts observed in both developed and developing nations.1 In China, the average age of first pregnancy has increased by 1.65 years between 2013–2019, reflecting an annual delay of 0.3 years.2 This trend is driven by complex socioeconomic factors, including rising costs of living, educational attainment, career prioritization, and declining fertility intentions.3 Concurrently, ART has emerged as a critical intervention, with over 10 million children born through ART procedures worldwide since 1987.4 However, the intersection of AMA and ART presents unique clinical challenges that warrant rigorous investigation.
While ART enables pregnancy achievement in older women, its impact on perinatal outcomes remains controversial. Existing evidence underscores AMA as an independent risk factor for adverse maternal outcomes including gestational hypertension, preeclampsia, and gestational diabetes mellitus.5 Neonatal risks are equally pronounced, with meta-analyses demonstrating elevated rates of preterm birth and low birth weight in AMA pregnancies.6 These risks may be compounded by ART, which has been associated with placental dysfunction through mechanisms such as impaired trophoblast invasion and epigenetic modifications.7 Notably, For AMA women, IVF-ET pregnancy may lead to a higher incidence of pregnancy complications and adverse delivery outcomes, but this might be due to an increased rate of multiple pregnancies.8
Some studies report that ART does not independently increase risks when controlling for age,9 whereas others demonstrate higher rates of placental-mediated complications in ART pregnancies.10 These discrepancies may stem from heterogeneous study populations, with most evidence derived from mixed-age cohorts or multifetal pregnancies.
Notably, primiparous AMA women represent a distinct high-risk subgroup. Primiparity compounds age-related risks due to nulliparous uterine vascular adaptation,5 yet limited data exist focusing exclusively on this population. Existing studies either combine multiparous women11 or lack adjustment for critical confounders like parity.12 This knowledge gap impedes evidence-based counseling for the growing cohort of AMA primiparas opting for ART.
To address these limitations, we conducted this retrospective cohort study comparing 2329 AMA primiparous women with singleton pregnancies, rigorously controlling for maternal age and parity. Our study aims to: Quantify the independent effect of ART on maternal and neonatal outcomes in AMA primiparas; Identify risk profiles specific to this population to guide clinical management.
Patients and Methods
Study Design and Population
This retrospective cohort study was conducted at Northwest Women’s and Children’s Hospital, a tertiary care center in Xi’an, China. We analyzed data from 2329 primiparous women aged ≥35 years who delivered singleton live births between January 1, 2016, and January 1, 2020. Participants were stratified into two groups based on conception method: the ART group (n=422) comprising women who underwent in vitro fertilization and embryo transfer (IVF-ET), and the spontaneous conception (SC) group (n=1907).
Inclusion and Exclusion Criteria
Inclusion criteria: Primiparous women aged ≥35 years at delivery. Singleton pregnancy ≥28 weeks gestation. Complete medical records available. For ART group: only IVF-ET cycles included (excluding cases with fetal reduction). Exclusion criteria: (1) Pre-pregnancy comorbidities of serious medical conditions (cardiovascular, hepatic, renal, or immune system diseases); (2) Multifetal pregnancies or incomplete clinical data. The general maternal conditions, maternal outcomes and infant outcomes of the two groups were retrospectively analysed. This retrospective study utilized anonymized clinical data extracted from electronic medical records. The Ethics Committee of Northwest Women’s and Children’s Hospital waived the requirement for individual informed consent as the research involved no more than minimal risk to participants and used pre-existing de-identified data (Approval No. 2022-049). This study complies with the Declaration of Helsinki.
Diagnostic Criteria
All diagnoses were made according to the 9th edition of Chinese “Obstetrics and Gynecology”.13 Comparing the following outcomes in two groups: hypertensive disorders of pregnancy, pre-eclampsia, gestational diabetes mellitus, diabetes mellitus combined with pregnancy, anaemia, placental abruption, premature rupture of membranes, intrahepatic cholestasis in pregnancy, post-partum haemorrhage, stillbirths, foetal distress, low birth weight babies, macrosomic babies and preterm births.
Statistical Analysis
Data analysis was performed using SPSS 26.0 (IBM Corp., Armonk, NY, USA). Continuous variables were presented as mean ± standard deviation (SD) and compared using Student’s t-test or Mann–Whitney U-test, as appropriate. Categorical variables were expressed as frequencies (%) and analyzed using the chi-square test or Fisher’s exact test. Multivariate logistic regression was performed to adjust for maternal age, BMI, and parity. Variables with p<0.1 in univariate analysis were included in the final model. Adjusted odds ratios (aORs) with 95% confidence intervals (CIs) were calculated to determine independent associations. A two-tailed P-value <0.05 was considered statistically significant.
Results
Baseline Characteristics
The ART group demonstrated significantly higher maternal age (37.48±2.44 years vs 36.65±1.90 years, p<0.001) and BMI (27.79±3.34 kg/m² vs 27.61±8.12 kg/m², p=0.016) compared to the spontaneous conception (SC) group. The proportion of women aged ≥40 years was markedly higher in the ART group (22.04% vs 8.65%, p<0.001). Gestational age at delivery was significantly shorter in ART pregnancies (38.49±1.95 weeks vs 38.97±1.71 weeks, p<0.001), while neonatal birth weights showed no statistical difference between groups (3224.45±575.56g vs 3275.90±513.07g, p=0.312) (Table 1).
Table 1 Comparison of Baseline Characteristics Between ART and Spontaneous Conception (SC) Groups
|
Maternal Outcomes
The ART group exhibited significantly higher rates of: Preeclampsia (9.24% vs 5.14%, χ²=10.51, p=0.001), Cesarean delivery (80.09% vs 63.08%, χ²=44.67, p<0.001); Conversely, the SC group demonstrated higher incidence of: Preterm premature rupture of membranes (PPROM) (26.43% vs 17.30%, χ²=15.46, p<0.001), No significant differences were observed in: Gestational hypertension (11.61% vs 9.28%, p=0.143), Gestational diabetes mellitus (33.18% vs 31.31%, p=0.455), Placental abruption (0.95% vs 1.42%, p=0.313) Postpartum hemorrhage (1.42% vs 2.36%, p=0.234) (Table 2).
![]() |
Table 2 Comparison of Pregnancy Complications and Neonatal Outcome Between the Two Groups [n (%)]
|
Neonatal Outcome
ART-conceived neonates showed significantly higher rates of: Low birth weight (9.24% vs 6.14%, χ²=5.34, p=0.021), Preterm birth (11.85% vs 8.02%, χ²=6.36, p=0.012), NICU admission (13.27% vs 6.08%, χ²=26.13, p<0.001), No significant differences were found in: Stillbirth (0% vs 0.26%, p=0.368), Fetal distress (3.08% vs 2.99%, p=0.921), Macrosomia (6.16% vs 6.03%, p=0.919), Neonatal malformations (1.18% vs 0.89%, p=0.367). Key findings are summarized in Tables 1 and 2, presenting both unadjusted and adjusted analyses for comprehensive assessment of outcomes (Table 2).
To control for potential confounders including maternal age, BMI, and parity, we performed multivariate logistic regression analysis (Table 3). ART remained independently associated with:
- Preeclampsia (adjusted odds ratio [aOR] 1.89, 95% confidence interval [CI] 1.25–2.86)
- Cesarean delivery (aOR 2.31, 95% CI 1.74–3.06)
- Preterm birth (aOR 1.55, 95% CI 1.10–2.19)
- NICU admission (aOR 2.38, 95% CI 1.68–3.37)
![]() |
Table 3 Multivariate Logistic Regression Analysis of ART-Associated Outcomes (Adjusted for Maternal Age and BMI)
|
No significant associations were found between ART and gestational diabetes mellitus (aOR 1.12, 95% CI 0.89–1.41), placental abruption (aOR 0.67, 95% CI 0.23–1.95), or postpartum hemorrhage (aOR 0.60, 95% CI 0.26–1.39).
Discussion
This large retrospective cohort study of 2329 advanced maternal age (AMA) primiparous women demonstrated that ART-conceived pregnancies were independently associated with increased risks of preeclampsia (aOR 1.89), cesarean delivery (aOR 2.31), preterm birth (aOR 1.55), and NICU admission (aOR 2.38) compared to spontaneous conceptions, even after adjusting for maternal age and BMI. These findings align with existing evidence highlighting the interplay between ART and placental dysfunction,10 while also revealing unique insights specific to AMA primiparas—a population that has been understudied in prior research.8,14
Characteristics of Pregnancy Risks for AMA Primiparous Women
AMA primiparous births are now becoming more common, with an increase in the age of first-time births possibly associated with women marrying later,15 and anxiety during pregnancy and negative overall experiences of labour are more common among older first-time parents.16 Older women have a higher risk of delivering preterm and low birth weight babies, which have long term negative effects on both the child and the mother.17 The present study, after excluding twin births and repeat pregnancies in advanced maternal age, showed that the mean age (37.48 years) and the percentage of ultra-advanced age (≥40 years) was significantly higher in the ART group (22.04%), which is in line with the findings of another study of ultra-AMA and these differences may be related to defective placenta function in pregnant women on ART.14 Placental hypofunction due to advanced age may explain the shorter gestational weeks of delivery in the ART group (38.49 weeks vs 38.97 weeks, p<0.001). Of note, despite a higher BMI in the ART group (27.79 kg/m2 vs 27.61 kg/m2), there was no significant difference in the incidence of gestational diabetes mellitus (33.18% vs 31.31%, P=0.455), suggesting that age, rather than ART per se, may be the main cause of metabolic disturbances.
Selective Risks of ART
ART has been widely used in elderly primigravid women, in this study, the percentage of super-elderly primigravid women with ART pregnancies reached 22%, while the percentage of super-elderly primigravid women with natural pregnancies was only 8.65%, which indicates that the percentage of super-elderly primigravid women opting for ART pregnancies is more significantly higher, which is in line with the conclusions of other studies.18,19 Some studies have concluded that assisted reproductive pregnancies do not appear to increase the risk of complications during pregnancy and perinatal outcomes in advanced maternal age,20 while others have concluded the opposite,21,22 that women with ART pregnancies have a higher cesarean section rate, obstetrical complications, and the risk of adverse fetal outcomes relative to spontaneous conception among women of advanced maternal age, but that these risks may be associated with an increase in the rate of twin pregnancies,8 the cesarean section rate in the ART group in this study was 80.09% vs 63.08%, which, in addition to the factor of advanced age, may be related to the excessive intervention of doctors and patients on the “precious child”, and we need to be vigilant about the long-term complications associated with non-medically indicated cesarean section.
In this study, after excluding the influence of multiple pregnancy factors, we found that among perinatal complications, only the incidence of premature rupture of membranes was significantly different between the two groups, and the pregnant women with natural pregnancy were significantly higher than those in the ART group (26.43% vs 17.30%), while no significant differences were observed in other aspects, which may be related to the higher average age of ART pregnant women and more medical treatment received before pregnancy, both the Pregnant women and doctors psychologically attached more importance to the outcome of this pregnancy and more often chose elective caesarean section delivery rather than waiting for spontaneous labour.
The incidence of perinatal complications such as hypertensive disorders of pregnancy and gestational diabetes mellitus in the present study did not differ between the two groups, which is in line with the findings of other studies.8,23 The significantly elevated risk of preeclampsia in ART pregnancies (aOR 1.89, 95% CI 1.25–2.86) aligns with current understanding of ART-associated placental dysfunction,10 the potential mechanisms may explain this association: Corpus luteum deficiency: Most ART cycles in our cohort used GnRH agonist protocols, which are known to suppress endogenous luteal function, potentially limiting production of vasoactive relaxin crucial for maternal cardiovascular adaptation.24 Trophoblast invasion impairment: The supraphysiological hormonal environment during ovarian stimulation may disrupt normal trophoblast invasion and spiral artery remodeling.25 Epigenetic modifications: In vitro culture conditions could induce epigenetic changes affecting placental development.8
Neonatal Outcomes: Reconciling Controversies
While ART-conceived neonates had higher rates of preterm birth and NICU admission, other outcomes (eg, stillbirth, fetal distress, macrosomia) showed no significant differences compared to SC neonates. This selective risk profile aligns with recent studies suggesting that ART primarily impacts fetal growth restriction and prematurity rather than congenital anomalies.12,26,27 However, the twofold increase in NICU admissions highlights the need for enhanced postnatal surveillance in this population.28
Research Strengths and Limitations
The strengths of this study are: (1) focusing on singleton pregnancy and excluding the confounding factors of multiple pregnancies; (2) large sample size (n=2329), more representative data; (3) the first systematic analysis of elderly primigravid women in Northwest China. However, the study has the following limitations: (1) it did not differentiate between fresh and frozen-thawed embryo transfer cycles, which may have different effects on pregnancy outcomes; (2) Absence of placental pathology data to explore preeclampsia mechanisms; and (3) the retrospective design may introduce selection bias. Future multicentre prospective studies combining placental pathology and long-term follow-up data in children are needed to further validate the findings.
Conclusion
In conclusion, our findings substantiate that ART in AMA primiparas confers selective perinatal risks requiring tailored clinical pathways. These results should inform international guidelines while highlighting the need for continued research into optimizing outcomes for this growing patient population.
Author Contributions
All authors made significant contributions to conception, study design, data acquisition, analysis, and interpretation; participated in drafting or critically revising the article; approved the final version; agreed on the target journal; and take responsibility for all aspects of the work.
Disclosure
All authors report no conflicts of interest in this work.
References
1. Office for National Statistics (ONS), released 17 May 2024, ONS website, statistical bulletin, Birth characteristics in England and Wales: 2022. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/livebirths/bulletins/birthcharacteristicsinenglandandwales/2022.
2. Mao Y, Zeng S, Han C, et al. Analysis of pregnancy age of rural planned pregnancy primigravida in Min xian County, Gansu Province, 2013_2019. China Fam Plann Obstet Gynaecol. 2021;13(12):83–86.
3. Ren ZP, Xiong C, Zhou Z. China fertility report 2019. Dev Res. 2019;2019(06):20–40.
4. Adamson GD, Creighton P, de Mouzon J, Zegers-Hochschild F, Dyer S, Chambers GM. How many infants have been born with the help of assisted reproductive technology? Fertil Steril. 2025;124:40–50. doi:10.1016/j.fertnstert.2025.02.009
5. Morton JS, Care AS, Kirschenman R, Cooke CL, Davidge ST. Advanced maternal age worsens postpartum vascular function. Front Physiol. 2017;8:465. doi:10.3389/fphys.2017.00465
6. Saccone G, Gragnano E, Ilardi B, et al. Maternal and perinatal complications according to maternal age: a systematic review and meta-analysis. Int J Gynaecol Obstet. 2022;159(1):43–55. doi:10.1002/ijgo.14100
7. Choux C, Carmignac V, Bruno C, et al. The placenta: phenotypic and epigenetic modifications induced by Assisted Reproductive Technologies throughout pregnancy. Clin Epigenet. 2015;7:87. doi:10.1186/s13148-015-0120-2
8. Lang M, Zhou M, Lei R, Li W. Comparison of pregnancy outcomes between IVF-ET pregnancies and spontaneous pregnancies in women of advanced maternal age. J Matern Fetal Neonatal Med. 2023;36(1):2183761. doi:10.1080/14767058.2023.2183761
9. Kalayci H, Ozdemir H, Alkas D, Cok T, Tarim E. Is primiparity a risk factor for advanced maternal age pregnancies? J Matern Fetal Neonatal Med. 2016;30(11):1283–1287. doi:10.1080/14767058.2016.1211633
10. Chih HJ, Elias FTS, Gaudet L, Velez MP. Assisted reproductive technology and hypertensive disorders of pregnancy: systematic review and meta-analyses. BMC Pregnancy Childbirth. 2021;21(1):449. doi:10.1186/s12884-021-03938-8
11. Marozio L, Picardo E, Filippini C, et al. Maternal age over 40 years and pregnancy outcome: a hospital-based survey. J Matern Fetal Neonatal Med. 2019;32(10):1602–1608. doi:10.1080/14767058.2017.1410793
12. Kawwass JF, Badell ML. Maternal and fetal risk associated with assisted reproductive technology. Obstet Gynecol. 2018;132(3):763–772. doi:10.1097/AOG.0000000000002786
13. Xie X, Kong B, Duan T. Obstetrics and Gynaecology.
14. Jackson S, Hong C, Wang ET, Alexander C, Gregory KD, Pisarska MD. Pregnancy outcomes in very advanced maternal age pregnancies: the impact of assisted reproductive technology. Fertil Steril. 2015;103(1):76–80. doi:10.1016/j.fertnstert.2014.09.037
15. Chen W, Duan Y. Recent levels and trends of fertility in China. Popul Res. 2019;43(1):3–17.
16. Waldenström U. Postponing parenthood to advanced age. Ups J Med Sci. 2016;121(4):235–243. doi:10.1080/03009734.2016.1201553
17. Sydsjö G, Lindell Pettersson M, Bladh M, Skoog Svanberg A, Lampic C, Nedstrand E. Evaluation of risk factors’ importance on adverse pregnancy and neonatal outcomes in women aged 40 years or older. BMC Pregnancy Childbirth. 2019;19(1):92. doi:10.1186/s12884-019-2239-1
18. Tambvekar SE, Adki S, Sheriar NK. Pregnancies in elderly mothers over 40 years: what to expect from the rising new age high-risk cohort? J Obstet Gynaecol India. 2023;73(4):358–362. doi:10.1007/s13224-022-01701-3
19. Juneja SK, Tandon P, Kaur G. To evaluate the effect of increasing maternal age on maternal and neonatal outcomes in pregnancies at advanced maternal age. Int J Appl Basic Med Res. 2022;12(4):239–242. doi:10.4103/ijabmr.ijabmr_193_22
20. Kalayci H, Ozdemir H, Alkas D, Cok T, Tarim E. Is primiparity a risk factor for advanced maternal age pregnancies? J Matern Fetal Neonatal Med. 2017;30(11):1283–1287. doi:10.1080/14767058.2016.1211633
21. Wu Y, Chen Y, Shen M, et al. Adverse maternal and neonatal outcomes among singleton pregnancies in women of very advanced maternal age: a retrospective cohort study. BMC Pregnancy Childbirth. 2019;19(1):3. doi:10.1186/s12884-018-2147-9
22. Frati P, Foldes-Papp Z, Panici PB, et al. A retrospective study on advanced maternal age and assisted reproductive techniques, medico-legal advice, “Food for Thought”. Curr Pharm Biotechnol. 2016;17(4):330–336. doi:10.2174/1389201017666151231095546
23. Yuan CL, He MR, He SM, Huang JC, Jian WQ, Zhao KS. Differences in pregnancy outcomes between in vitro fertilization and natural conception in nulliparous singleton pregnancies of advanced maternal age: a study based on propensity score matching and cohort retrospective analysis. Int J Womens Health. 2025;17:947–954. doi:10.2147/IJWH.S510393
24. Dall’Agnol H, García Velasco JA. Frozen embryo transfer and preeclampsia: where is the link? Curr Opin Obstet Gynecol. 2020;32(3):213–218. doi:10.1097/GCO.0000000000000624
25. Chang KJ, Seow KM, Chen KH. Preeclampsia: recent advances in predicting, preventing, and managing the maternal and fetal life-threatening condition. Int J Environ Res Public Health. 2023;20(4):2994. doi:10.3390/ijerph20042994
26. Harlev A, Walfisch A, Oran E, et al. The effect of fertility treatment on adverse perinatal outcomes in women aged at least 40 years. Int J Gynaecol Obstet. 2018;140(1):98–104. doi:10.1002/ijgo.12345
27. Lagrew DC, Morgan MA, Nakamoto K, Lagrew N. Advanced maternal age: perinatal outcome when controlling for physician selection. J Perinatol. 1996;16(4):256–260.
28. Pettersson ML, Bladh M, Nedstrand E, Svanberg AS, Lampic C, Sydsjö G. Maternal advanced age, single parenthood, and ART increase the risk of child morbidity up to five years of age. BMC Pediatr. 2022;22(1):39. doi:10.1186/s12887-021-03103-2